Skip to content
Open global navigation

Cambridge University Press

AcademicLocation selectorSearch toggleMain navigation toggle
Cart
Register Sign in Wishlist

Incentives for Global Public Health
Patent Law and Access to Essential Medicines

$133.00

Part of Connecting International Law with Public Law

Thomas Pogge, Matthew Rimmer, Kim Rubenstein, Rochelle Cooper Dreyfuss, Andrew Mitchell, Tania Voon, Hitoshi Nasu, Elizabeth Siew Kuan Ng, Kathleen Liddell, William W. Fisher, Talha Syed, Thomas Faunce, Dianne Nicol, Jane Nielsen, Charles Lawson, Barbara Hocking, Noah Benjamin Novogrodsky, Katharine Young, Rajshree Chandra, Jonathan Burton-MacLeod
View all contributors
  • Date Published: July 2010
  • availability: In stock
  • format: Hardback
  • isbn: 9780521116565
Average user rating
(1 review)

$133.00
Hardback

Add to cart Add to wishlist

Other available formats:
Paperback, eBook


Looking for an examination copy?

This title is not currently available for examination. However, if you are interested in the title for your course we can consider offering an examination copy. To register your interest please contact collegesales@cambridge.org providing details of the course you are teaching.

Description
Product filter button
Description
Contents
Resources
About the Authors
  • This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of 'creative capitalism'.

    • Connects international and public law, extending each discipline's understanding of the other
    • Explores institutional mechanisms that would create additional incentives to develop essential medicines while also ensuring real access to the new products even for the world's poorest populations
    • Provides policy impetus to those working in the area of global health
    Read more

    Customer reviews

    17th Nov 2013 by Kavin

    This is a well edited collection from leading international scholars on the subject of global health, one that provides comprehensive analysis on the role of innovation in promoting health. Although the literature on this subject is vast, this volume presents new and challenging insights. Short, focussed chapters cover a good breadth of topics and shed fresh and clear light on the public side of the debate on access to essential medicines.

    Review was not posted due to profanity

    ×

    , create a review

    (If you're not , sign out)

    Please enter the right captcha value
    Please enter a star rating.
    Your review must be a minimum of 12 words.

    How do you rate this item?

    ×

    Product details

    • Date Published: July 2010
    • format: Hardback
    • isbn: 9780521116565
    • length: 536 pages
    • dimensions: 235 x 158 x 29 mm
    • weight: 0.98kg
    • availability: In stock
  • Table of Contents

    Introduction: access to essential medicines: public health and international law Thomas Pogge, Matthew Rimmer and Kim Rubenstein
    Part I. International Trade:
    1. TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis Rochelle Cooper Dreyfuss
    2. The TRIPS waiver as a recognition of public health concerns in the WTO Andrew Mitchell and Tania Voon
    3. Public law challenges to the regulation of pharmaceutical patents in the US Bilateral Free Trade Agreements Hitoshi Nasu
    4. Global health and development: patents and public interest Elizabeth Siew Kuan Ng
    Part II. Innovation:
    5. The Health Impact Fund: boosting innovation without obstructing free access Thomas Pogge
    6. The Health Impact Fund: a critique Kathleen Liddell
    7. A prize system as a partial solution to the health crisis in the developing world William W. Fisher and Talha Syed
    8. Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation Thomas Faunce
    Part III. Intellectual Property:
    9. Opening the dam: patent pools, innovation, and access to essential medicines Dianne Nicol and Jane Nielsen
    10. Open source drug discovery: a revolutionary paradigm or a utopian model? Krishna Ravi Srinivas
    11. Accessing and benefit sharing avian influenza viruses through the World Health Organization: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? Charles Lawson and Barbara Hocking
    12. The Lazarus effect: the (RED) campaign and creative capitalism Matthew Rimmer
    Part IV. Health-Care:
    13. Beyond TRIPS: the role of non-state actors and access to essential medicines Noah Benjamin Novogrodsky
    14. Securing health through rights Katharine Young
    15. The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India Rajshree Chandra
    16. Tipping point: Thai compulsory licenses redefine essential medicines debate Jonathan Burton-MacLeod.

  • Editors

    Thomas Pogge, Yale University, Connecticut
    fm.author_biographical_note1

    Matthew Rimmer, Australian National University, Canberra
    fm.author_biographical_note2

    Kim Rubenstein, Australian National University, Canberra
    fm.author_biographical_note3

    Contributors

    Thomas Pogge, Matthew Rimmer, Kim Rubenstein, Rochelle Cooper Dreyfuss, Andrew Mitchell, Tania Voon, Hitoshi Nasu, Elizabeth Siew Kuan Ng, Kathleen Liddell, William W. Fisher, Talha Syed, Thomas Faunce, Dianne Nicol, Jane Nielsen, Charles Lawson, Barbara Hocking, Noah Benjamin Novogrodsky, Katharine Young, Rajshree Chandra, Jonathan Burton-MacLeod

Sign In

Please sign in to access your account

Cancel

Not already registered? Create an account now. ×

You are now leaving the Cambridge University Press website, your eBook purchase and download will be completed by our partner www.ebooks.com. Please see the permission section of the www.ebooks.com catalogue page for details of the print & copy limits on our eBooks.

Continue ×

Continue ×

Find content that relates to you

© Cambridge University Press 2014

Back to top

Are you sure you want to delete your account?

This cannot be undone.

Cancel Delete

Thank you for your feedback which will help us improve our service.

If you requested a response, we will make sure to get back to you shortly.

×
Please fill in the required fields in your feedback submission.
×